‘Calcium drugs’ utilizing osteoporosis prevention and treatment increase the risk of cardiovascular disease> News
The medical newspaper mobile site takes the first step in developing a treatment for the rare disease’extinction white disease
JW Choongwae Pharm, applied for product approval of’Rivarojet’, a new complex drug for hyperlipidemia
JW Choongwae Pharmaceutical’s new complex drug for hyperlipidemia, Rivarojet product license application
JW Choongwae Pharmaceutical proves lipid-improving effect as a result of Phase 3 clinical trial of RivaroJet’NDA application’
JW Choongwae Pharmaceutical proves the effect of improving lipids in phase 3 clinical trials of ribarojet
![[건강]Calcium drugs for osteoporosis, cardiovascular disease risk 15%↑](http://www.getnews.co.kr/image/logo/snslogo_20201026012739.jpg "[건강]Calcium drugs for osteoporosis, cardiovascular disease risk 15%↑"){kind=logo}
